JNJ Johnson & Johnson

Price (delayed)

$148

Market cap

$389.66B

P/E Ratio

25.61

Dividend/share

$3.86

EPS

$5.78

Enterprise value

$408.88B

Sector: Healthcare
Industry: Drug Manufacturers - General
Johnson & Johnson is a holding company, which engages in the research and development, manufacture and sale of products in the health care field. It operates through the following segments: Consumer, Pharmaceutical, and Medical Devices. The Consumer segment includes products used in the baby care, oral care, beauty, over-the-counter pharmaceutical, women's health, and wound care markets. The Pharmaceutical segment focuses on therapeutic areas such as immunology, infectious diseases ad vaccines, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The Medical Devices segment offers products used in the orthopedic, surgery, cardiovascular, diabetes care, and eye health fields. The company was founded by Robert Wood Johnson I, James Wood Johnson and Edward Mead Johnson Sr. in 1886 and is headquartered in New Brunswick, NJ.

Highlights

JNJ's equity is up by 3.6% year-on-year and by 2.7% since the previous quarter
JNJ's price to earnings (P/E) is 63% lower than its 5-year quarterly average of 68.8 but 11% higher than its last 4 quarters average of 23.1
Johnson & Johnson's net income has decreased by 12% QoQ and by 7% YoY
The EPS has contracted by 11% from the previous quarter and by 6% YoY

Key stats

What are the main financial stats of JNJ
Market
Shares outstanding
2.63B
Market cap
$389.66B
Enterprise value
$408.88B
Valuations
Price to earnings (P/E)
25.61
Price to book (P/B)
6.19
Price to sales (P/S)
4.84
EV/EBIT
24.75
EV/EBITDA
17.37
EV/Sales
5.08
Earnings
Revenue
$80.5B
EBIT
$16.52B
EBITDA
$23.53B
Free cash flow
$17.44B
Per share
EPS
$5.78
Free cash flow per share
$6.63
Book value per share
$23.9
Revenue per share
$30.58
TBVPS
$29.27
Balance sheet
Total assets
$158.38B
Total liabilities
$95.4B
Debt
$30.39B
Equity
$62.98B
Working capital
$9.12B
Liquidity
Debt to equity
0.48
Current ratio
1.25
Quick ratio
0.92
Net debt/EBITDA
0.82
Margins
EBITDA margin
29.2%
Gross margin
65.7%
Net margin
18.9%
Operating margin
24.6%
Efficiency
Return on assets
9.7%
Return on equity
25.1%
Return on invested capital
30.7%
Return on capital employed
13.6%
Return on sales
20.5%
Dividend
Dividend yield
2.61%
DPS
$3.86
Payout ratio
66.8%

JNJ stock price

How has the Johnson & Johnson stock price performed over time

Financial performance

How have Johnson & Johnson's revenue and profit performed over time
Revenue
$80.5B
Gross profit
$52.86B
Operating income
$19.84B
Net income
$15.19B
Gross margin
65.7%
Net margin
18.9%
Johnson & Johnson's net income has decreased by 12% QoQ and by 7% YoY
Johnson & Johnson's operating margin has increased by 9% YoY but it has decreased by 3.9% from the previous quarter
Johnson & Johnson's net margin has decreased by 9% from the previous quarter and by 6% YoY
The operating income rose by 8% year-on-year but it has declined by 6% since the previous quarter

Valuation

What is Johnson & Johnson stock price valuation
P/E
25.61
P/B
6.19
P/S
4.84
EV/EBIT
24.75
EV/EBITDA
17.37
EV/Sales
5.08
JNJ's price to earnings (P/E) is 63% lower than its 5-year quarterly average of 68.8 but 11% higher than its last 4 quarters average of 23.1
The EPS has contracted by 11% from the previous quarter and by 6% YoY
JNJ's price to book (P/B) is 19% more than its 5-year quarterly average of 5.2 and 7% more than its last 4 quarters average of 5.8
JNJ's equity is up by 3.6% year-on-year and by 2.7% since the previous quarter
The price to sales (P/S) is 13% more than the last 4 quarters average of 4.3 and 10% more than the 5-year quarterly average of 4.4
JNJ's revenue is down by 2.7% since the previous quarter

Efficiency

How efficient is Johnson & Johnson business performance
Johnson & Johnson's return on invested capital has decreased by 18% QoQ and by 9% YoY
The ROS has contracted by 15% YoY and by 14% from the previous quarter
The company's return on equity fell by 12% QoQ and by 6% YoY
The return on assets has declined by 12% since the previous quarter and by 9% year-on-year

Dividends

What is JNJ's dividend history
DPS
$3.86
Dividend yield
2.61%
Payout ratio
66.8%
Recent dividends

Financial health

How did Johnson & Johnson financials performed over time
JNJ's total assets is 66% greater than its total liabilities
The quick ratio has decreased by 6% QoQ and by 3.2% YoY
JNJ's current ratio is down by 6% year-on-year and by 4.6% since the previous quarter
Johnson & Johnson's debt is 52% less than its equity
Johnson & Johnson's debt has increased by 10% from the previous quarter and by 3.3% YoY
JNJ's equity is up by 3.6% year-on-year and by 2.7% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.